Chronic infection in the aetiology of atherosclerosis--focus on Chlamydia pneumoniae
1Department of Cardiological Sciences, St George's Hospital Medical School, London, UK. sgupta@sghms.ac.uk
Abstract:
An inflammatory basis to atherosclerosis is now accepted. It remains plausible (but unproven) that common infectious agents may contribute to the inflammatory signal, and hence the development (and/or progression of atherosclerosis and its clinical sequelae. Of the candidate microorganisms implicated, Chlamydia pneumoniae has emerged as the most likely pathogen to have a casual role. Evidence for this is based on sero-epidemiological, pathological and laboratory-based evidence, in addition to early animal models and small-scale antibiotic studies. A past decade of research has now culminated in prospective antibiotic intervention trials in coronary heart disease to be conducted. The results of these studies should help to finally determine whether infection with C. pneumoniae is a pathogenetic factor in atherosclerosis, and whether antibiotic therapy has a role in the secondary prevention of coronary heart disease.
Related Concept Videos
Bacterial Phylum Chlamydiae
Atypical Pneumonia
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
